Insider Trading activities of Amneal Pharmaceuticals, Inc. (AMRX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amneal Pharmaceuticals, Inc. (AMRX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amneal Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Amneal Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is AMRX. The reporting company's CIK number is 1723128.
The total value of stock buying since 2005 is $793,430.
The total value of stock sales since 2005 is $856,738,918.
The total value of stock option exercises since 2005 is $491,250.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Amneal Pharmaceuticals, Inc. (AMRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 41,000 $387,300 0 $0 200,974 $0
2019-03 34,000 $406,130 23,345 $289,244 45,000 $294,750
2019-01 0 $0 0 $0 30,000 $196,500
2018-08 0 $0 61,698 $1,449,657 0 $0
2018-05 0 $0 46,849,316 $855,000,017 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Amneal Pharmaceuticals, Inc. insiders (AMRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-15 Bhadauria Pradeep (SVP, Chief Scientific Officer) Buy 7,000 8.48 59,360
2019-05-13 Todisco Joseph (SVP, Specialty Commercial) Buy 15,000 9.88 148,200
2019-05-13 Boyer Andrew S (Exec VP, Comm Optns) Buy 19,000 9.46 179,740
2019-05-08 Patel Chirag K. Option Ex 6,107 .00 0
2019-05-08 Alva Emily Peterson Option Ex 6,107 .00 0
2019-05-08 Rama Dharmendra Option Ex 6,107 .00 0
2019-05-08 Patel Gautam Option Ex 6,107 .00 0
2019-05-08 Greene Jean Selden Option Ex 6,107 .00 0
2019-05-08 Patel Chintu Option Ex 6,107 .00 0
2019-05-08 Vergis Janet S. Option Ex 6,107 .00 0
2019-05-08 Nark Ted C Option Ex 6,107 .00 0
2019-05-08 Burr Robert L Option Ex 6,107 .00 0
2019-05-08 Terreri Peter R Option Ex 6,107 .00 0
2019-05-08 Buchi J Kevin Option Ex 6,107 .00 0
2019-05-07 Todisco Joseph (SVP, Specialty Commercial) Option Ex 4,441 .00 0
2019-05-07 Shah Nikita (SVP, Chief HR Officer) Option Ex 4,441 .00 0
2019-05-07 Stewart Robert A (President and CEO) Option Ex 83,277 .00 0
2019-05-07 Boyer Andrew S (Exec VP, Comm Optns) Option Ex 16,655 .00 0
2019-05-07 Bisaro Paul (Executive Chairman) Option Ex 24,983 .00 0
2019-03-12 Stewart Robert A (President and CEO) Buy 17,000 11.92 202,640
2019-03-12 Bisaro Paul (Executive Chairman) Buy 17,000 11.97 203,490
2019-03-06 Terreri Peter R Sale 23,345 12.39 289,244
2019-03-06 Terreri Peter R Option Ex 45,000 6.55 294,750
2019-01-15 Burr Robert L Option Ex 30,000 6.55 196,500
2018-08-21 Shah Nikita (SVP, Chief HR Officer) Sale 50,000 23.46 1,173,000
2018-08-21 Reasons Bryan M. (CFO) Sale 11,698 23.65 276,657
2018-05-04 Aphc Holdings, Llc (10% Owner) Sale 46,849,316 18.25 855,000,017

Insider trading activities including stock purchases, stock sales, and option exercises of AMRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amneal Pharmaceuticals, Inc. (symbol AMRX, CIK number 1723128) see the Securities and Exchange Commission (SEC) website.